GlassScriptPhysician profile
Logan Schamber
NPI 1235712316
$821.67
in general payments reported to CMS, 2019-2025
13 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.64 · 2022: $97.43 · 2023: $153 · 2024: $282 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $702 · Education: $5.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $701.79 |
| Education | $5.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $236.49 | 2023-2025 | Avycaz |
| Aurinia Pharma U.S., INC. | $124.93 | 2025 | Lupkynis |
| Boston Scientific Corporation | $97.43 | 2022 | |
| Exact Sciences Corporation | $80.73 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $54.25 | 2023-2024 | |
| Actelion Pharmaceuticals US, INC. | $52.13 | 2024-2025 | Opsumit, Uptravi |
| Novartis Pharmaceuticals Corporation | $39.90 | 2024 | |
| Mallinckrodt Hospital Products INC. | $36.14 | 2024-2025 | Terlivaz |
| Glaxosmithkline, LLC. | $35.82 | 2024 | Shingrix |
| Astrazeneca Pharmaceuticals LP | $22.17 | 2024 | Fasenra |
| Bayer Healthcare Pharmaceuticals INC. | $19.23 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.64 | 2021 | |
| Travere Therapeutics, INC. | $5.81 | 2025 | Filspari |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Schamber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.